Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an invasive ductal carcinoma in a contralateral composite nipple graft after an autologous breast reconstruction: a case report.
Kimura M, Narui K, Shima H, Ikejima S, Muto M, Satake T, Tanabe M, Inayama Y, Adachi S, Yamada A, Shimada K, Sugae S, Ichikawa Y, Ishikawa T, Endo I. Kimura M, et al. Among authors: shimada k. Surg Case Rep. 2020 Aug 8;6(1):203. doi: 10.1186/s40792-020-00962-2. Surg Case Rep. 2020. PMID: 32770432 Free PMC article.
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Kida K, Ishikawa T, Yamada A, Shimada K, Narui K, Sugae S, Shimizu D, Tanabe M, Sasaki T, Ichikawa Y, Endo I. Kida K, et al. Among authors: shimada k. Breast Cancer Res Treat. 2016 Apr;156(2):261-9. doi: 10.1007/s10549-016-3738-7. Epub 2016 Mar 14. Breast Cancer Res Treat. 2016. PMID: 26975188
First-line Gemcitabine Versus Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort Study.
Yamamoto S, Narui K, Ishikawa T, Adachi S, Shimada K, Shimizu D, Yamada A, Sugae S, Tanabe M, Oba M, Morita S, Doi T, Hasegawa S, Morita T, Kito A, Chishima T, Ichikawa Y, Endo I; YOKOHAMA CLINCAL ONCOLOGY GROUP. Yamamoto S, et al. Among authors: shimada k. Anticancer Res. 2021 Mar;41(3):1671-1676. doi: 10.21873/anticanres.14930. Anticancer Res. 2021. PMID: 33788764
A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.
Onishi H, Udagawa C, Kubo M, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Momozawa Y, Low SK, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Hartman M, Chan CW, Lee SC, Endo I, Zembutsu H. Onishi H, et al. Among authors: shimada k. PLoS One. 2018 Aug 30;13(8):e0201606. doi: 10.1371/journal.pone.0201606. eCollection 2018. PLoS One. 2018. PMID: 30161160 Free PMC article.
4,634 results